Hypoglycemic effect of Chrysanthemum morifolium extract on alloxan-induced diabetic mice is associated with peroxisome proliferator-activated receptor α/γ-mediated hepatic glycogen synthesis

Journal of Applied Biomedicine

Volumn 15, Issue 1, 2017, Pages 81-86

  Shang, Xiang ^a   Zhu, Zeng Yan ^a,b   Wang, Feng ^a   Liu, Jin Cheng ^a   Liu, Jiang Yun ^a   Xie, Mei Lin ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Blood glucose; Chrysanthemum morifolium extract; Glucose transporter 2; Glycogen synthase; Hepatic glycogen; Peroxisome proliferator activated receptor

Indexed keywords

CHRYSANTHEMUM EXTRACT; CHRYSANTHEMUM MORIFOLIUM EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 2; GLYCOGEN; GLYCOGEN SYNTHASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL; UNCLASSIFIED DRUG;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WEIGHT GAIN;

EID: 85008895458     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.1016/j.jab.2016.10.001     Document Type: Article

References (34)

1. Barroso, I., Gurnell, M., Crowley, V.E.F., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D.M., Lewis, H., Schafer, A.J., Chatterjee, V.K.K., O'Rahilly, S., Dominant negative mutations in human PPAR gamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999), 880–883.
2. Bezborodkina, N.N., Chestnova, A.Y., Okovity, S.V., Kudryavtsev, B.N., Activity of glycogen synthase and glycogen phosphorylase in normal and cirrhotic rat liver during glycogen synthesis from glucose or fructose. Exp. Toxicol. Pathol. 66 (2014), 147–154.
3. Cui, Y., Wang, X.L., Xue, J., Liu, J.Y., Xie, M.L., Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through PPARα-mediated mechanism in mice. Nutr. Res. 34 (2014), 268–275.
4. Desvergne, B., Wahli, W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999), 649–688.
5. Flavell, D.M., Ireland, H., Stephens, J.W., Hawe, E., Acharya, J., Mather, H., Hurel, S.J., Humphries, S.E., Peroxisome proliferator-activated receptor alpha gene variation influences ages of onset and progression of type 2 diabetes. Diabetes 54 (2005), 582–586.
6. Im, S.S., Kim, J.W., Kim, T.H., Song, X.L., Kim, S.Y., Kim, H.I., Ahn, Y.H., Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter. Exp. Mol. Med. 37 (2005), 101–110.
7. Jay, M.A., Ren, J., Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr. Diabetes Rev. 3 (2007), 33–39.
8. Jia, L.Y., Sun, Q.S., Huang, S.W., Comparison of various constituents in eight kinds of chrysanthemum. Chin. Tradit. Herb. Drugs 35 (2004), 1180–1183.
9. Jiang, H.D., Cai, J., Xu, J.H., Zhou, X.M., Xia, Q., Endothelium-dependent and direct relaxation induced by ethyl acetate extract from Flos Chrysanthemi in rat thoracic aorta. J. Ethnopharmacol. 101 (2005), 221–226.
10. Joussen, A.M., Doehmen, S., Le, M.L., Koizumi, K., Radetzky, S., Krohne, T.U., Poulaki, V., Semkova, I., Kociok, N., TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol. Vis. 15 (2009), 1418–1428.
11. Karthikesan, K., Pari, L., Menon, V.P., Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin-nicotinamide generated oxidative stress induced diabetes. J. Funct. Foods 2 (2010), 134–142.
12. Kersten, S., Integrated physiology and systems biology of PPARalpha. Mol. Metab. 3 (2014), 354–371.
13. Kim, H.J., Lee, Y.S., Identification of new dicaffeoylquinic acids from Chrysanthemum morifolium and their antioxidant activities. Planta Med. 71 (2005), 871–876.
14. Kwon, E.Y., Jung, U.J., Park, T., Yun, J.W., Choi, M.S., Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 64 (2015), 1658–1669.
15. Lee, J.S., Kim, H.J., Lee, Y.S., A new anti-HIV flavonoid from glucoronide from Chrysanthemum morifolium. Planta Med. 69 (2003), 859–861.
16. Lee, D.Y., Choi, G., Yoon, T., Cheon, M.S., Choo, B.K., Kim, H.K., Anti-inflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation. J. Ethnopharmacol. 123 (2009), 149–154.
17. Lenzen, S., The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 51 (2008), 216–226.
18. Lii, C.K., Lei, Y.P., Yao, H.T., Hsieh, Y.S., Tsai, C.W., Liu, K.L., Chen, H.W., Chrysanthemum morifolium Ramat: reduces the oxidized LDL-induced expression of intercellular adhesion molecule-1 and E-selectin in human umbilical vein endothelial cells. J. Ethnopharmacol. 128 (2010), 213–220.
19. Lin, L.Z., Harnly, J.M., Identification of the phenolic components of chrysanthemum flower (Chrysanthemum morifolium Ramat). Food Chem. 120 (2010), 319–326.
20. Miyazawa, M., Hisama, M., Anti-mutagenic activity of flavonoids from Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 67 (2003), 2091–2099.
21. Moore, D.J., Gregory, J.M., Kumah-Crystal, Y.A., Simmons, J.H., Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc. Health Risk Manage. 5 (2009), 1015–1031.
22. Mordes, J.P., Rossini, A.A., Animal models of diabetes. Am. J. Med. 70 (1981), 353–360.
23. Mueckler, M., Thorens, B., The SLC2 (GLUT) family of membrane transporters. Mol. Asp. Med. 34:SI (2013), 121–138.
24. Ortmeyer, H.K., Adall, Y., Marciani, K.R., Katsiaras, A., Ryan, A.S., Bodkin, N.L., Hansen, B.C., Skeletal muscle glycogen synthase subcellular localization: effects of insulin and PPAR-alpha agonist (K-111) administration in rhesus monkeys. Am. J. Physiol.-Reg. I 288 (2005), R1509–R1517.
25. Ren, B., Qin, W.W., Wu, F.H., Wang, S.S., Pan, C., Wang, L.Y., Zeng, B., Ma, S.P., Liang, J.Y., Apigenin and naringenin regulate glucose and lipid metabolism: and ameliorate vascular dysfunction in type 2 diabetic rats. Eur. J. Pharmacol. 773 (2016), 13–23.
26. Roach, P.J., Depaoli-Roach, A.A., Hurley, T.D., Tagliabracci, V.S., Glycogen and its metabolism: some new developments and old themes. Biochem. J. 441 (2012), 763–787.
27. Rusu, M.A., Tamas, M., Puica, C., Roman, I., Sabadas, M., The hepatoprotective action of ten herbal extracts in CCl4 intoxicated liver. Phytother. Res. 19 (2005), 744–749.
28. Shen, Z., Zhang, W.T., Huang, Q.W., Chen, L.Y., Zhao, W.L., RP-HPLC determination of 3,5-di-caffeoylquinic acid, luteolin-7-β-glucoside and chlorogenic acid in chrysanthemum. Chin. Tradit. Herb. Drugs 41 (2010), 307–310.
29. Ukiya, M., Akihisa, T., Yasukawa, K., Kasahara, Y., Kimura, Y., Koike, K., Nikaido, T., Takido, M., Constituents of compositae plants. 2. Triterpene diols, triols, and their 3-O-fatty acid esters from edible chrysanthemum flower extract and their anti-inflammatory effects. J. Agric. Food Chem. 49 (2001), 3187–3197.
30. Wang, Z., Clifford, M.N., Sharp, P., Analysis of chlorogenic acids in beverages prepared from Chinese health foods and investigation in vitro, of effects on glucose absorption in cultured Caco-2 cells. Food Chem. 108 (2008), 369–373.
31. Wang, Z.D., Huang, C., Li, Z.F., Yang, J., Li, B.H., Liang, R.R., Dai, Z.J., Liu, Z.W., Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol. Rep. 23 (2010), 413–421.
32. Xie, Y.Y., Qu, J.L., Wang, Q.L., Wang, Y., Yoshikawa, M., Yuan, D., Comparative evaluation of cultivars of Chrysanthemum morifolium flowers by HPLC-DAD-ESI/MS analysis and antiallergic assay. J. Agric. Food Chem. 60 (2012), 12574–12583.
33. Yang, L., Wei, D.D., Chen, Z., Wang, J.S., Kong, L.Y., Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum. Phytomedicine 18 (2011), 710–718.
34. Yoshikawa, M., Morikawa, T., Toguchida, I., Harima, S., Matsuda, H., Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes kikkanols D, D, monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chem. Pharm. Bull. 48 (2000), 651–656.